Physiologic MR Imaging of Salivary Gland Tumors
Physiologic MR Imaging in Distinguishing Benign From Malignant Salivary Gland Tumors
Abramson Cancer Center at Penn Medicine
30 participants
Aug 25, 2020
INTERVENTIONAL
Conditions
Summary
The goal of this study is to use advanced Magnetic Resonance Imaging (MRI) techniques to help identify the difference between cancerous and non-cancerous salivary gland tumors for improving treatment strategies and to aid in the prediction of disease progression.
Eligibility
Inclusion Criteria2
- Possess a salivary gland lesion of 1cm3 size
- Have no prior history of treatment for salivary gland lesion
Exclusion Criteria5
- Has any prior history of cancer other than SGT
- Has any MRI contra-indications
- Has a history of known renal disease.
- Has history of prior radiation to head and neck region
- Is pregnant
Interventions
You are being asked to complete one research MRI scan with and without contrast since your most recent clinical evaluation and/or prior imaging has shown the presence of a suspicious salivary gland tumor, prior to your scheduled upcoming surgery. MRI contrast agents act like a dye to make MRI pictures brighter and easier to read. During each MRI scan, you will have an intravenous line (IV line) placed. The IV line allows the contrast agent to be injected into your vein. If you have a history of renal disease you may be asked to complete a blood draw of approximately 2.5cc (½ teaspoon), for glomerular filtration rate (GFR) assessment for participation into the study.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04452162